e-learning
resources
Vienna 2009
Monday, 14.09.2009
Clinical immunology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
T spot TB reactivity – ²to treat or not to treat²
D. D‘Quino, A. Morris, J. Nash, B. Prathibha (Ashford, United Kingdom)
Source:
Annual Congress 2009 - Clinical immunology of tuberculosis
Session:
Clinical immunology of tuberculosis
Session type:
Thematic Poster Session
Number:
2571
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. D‘Quino, A. Morris, J. Nash, B. Prathibha (Ashford, United Kingdom). T spot TB reactivity – ²to treat or not to treat². Eur Respir J 2009; 34: Suppl. 53, 2571
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Definition and history of sarcoidosis
Asbestosis
Related content which might interest you:
LungPoint® – A new approach to peripheral lung lesions
Source: Annual Congress 2010 - Tissue is mostly the issue: diagnostic and therapeutic bronchoscopy
Year: 2010
Airway resistances: R
aw
, sR
aw
, sR
eff
– Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010
The results of drug resistance survey of MDR-strains on second line drugs obtains in national reference laboratory – " M.Nasta " Institute – Bucharest
Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2011
Evaluation of difficult asthma – a single centre experience
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Monitoring of efficacy of therapy with monoclonal antibodies – Omalizumab – Using the Recovery-ELISA
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
The emerging problem of treating pulmonary
M. avium complex
(MAC) disease – microbial substitution of MAC to
M. abscessus
,
Scedosporium
and
Nocardia
after multi-drug chemotherapy in pulmonary MAC disease
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009
Triple 0 – A new respiratory syndrome?
Source: Annual Congress 2012 - Advanced experience with long-term noninvasive ventilation and late-breaking abstracts
Year: 2012
Ways to shorten the lung clearance index measurement ΙΙ – How long to wash?
Source: Annual Congress 2012 - New developments in paediatric respiratory physiology
Year: 2012
Miliary tuberculosis during treatment with anti TNF alpha – A report of three cases
Source: Annual Congress 2012 - Tuberculosis: clinical findings I
Year: 2012
T spot TB – Changing trends and resource implications for trusts
Source: Annual Congress 2011 - Risk assessment for tuberculosis
Year: 2011
Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sG
eff
with FEV
1
and MEF
50
as target parameter
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012
Treatment of sarcoidosis – pentoxifylline
Source: Annual Congress 2009 - Pleural and parenchymal diseases
Year: 2009
Freeflowmetry – The new method of evaluation of the respiratory function phenotype
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Patients‘ knowledge about inhalation therapy in pulmology – One year after intervention
Source: Annual Congress 2011 - Medical education
Year: 2011
Tuberculosis – is there anything different over a decade?
Source: Annual Congress 2009 - Socio-economic impact of tuberculosis
Year: 2009
Pulmonary tuberculosis – Still a challenging diagnosis
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011
PCD – As serious as CF in every day lung clinic?
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Interferon gamma release assays in screening for tuberculosis – Can we use them in patients with sarcoidosis?
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011
Clinical evaluation in 14 cases of diffuse alveolar hemorrhage – Relationship between initial findings and prognosis –
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010
The specificity of a new skin test – Diaskintest (recombinant protein CFP10-ESAT6) in patients with sarcoidosis and non-tuberculous pulmonary diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept